NCT06244186
The Effect of Lactobacillus Delbrueckii Subsp. Bulgaricus on Human's Weight Reduction
China Medical University Hospital·ClinicalTrials.gov·dietary supplementCompleted
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Overweight and Obesity
- Drug/Device/Intervention
- Probiotics
- Study type
- Interventional
- Intervention type
- dietary supplement
Sponsor & location
- Primary sponsor
- China Medical University Hospital
- Location
- Taichung, Taiwan
Timeline & enrollment
- Phase
- N/A
- Start date
- Sep 10, 2021
- End date
- Nov 03, 2023
- Enrollment
- 36 participants
Primary outcome
Body weight,Body fat,BMI
Summary
To evaluate the improvement in weight, body fat, and BMI after adding probiotics as a
 once-daily therapy for 84 days in overweight individuals.
ICD-10 classifications
ObesityOther obesityObesity due to excess caloriesObesity, unspecifiedObesity and other hyperalimentation
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06244186
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06244186 through Pure Global AI's free database. This phase not specified trial is sponsored by China Medical University Hospital and is currently Completed. The study focuses on Overweight and Obesity. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.